img

Global and India Anti-VEGF Drug Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and India Anti-VEGF Drug Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and India Anti-VEGF Drug Market
This report focuses on global and India Anti-VEGF Drug market, also covers the segmentation data of other regions in regional level and county level.
The global Anti-VEGF Drug revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period (2024-2034).
In India the Anti-VEGF Drug revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Anti-VEGF Drug include F. Hoffmann-La Roche Ltd, Amgen Inc, Pfizer, Inc, Xbrane Biopharma AB, Allergan, Bayer AG, Regeneron Pharmaceuticals Inc. and Viatris Inc, etc. The global five biggest players hold a share of % in 2024.
Global Anti-VEGF Drug Scope and Market Size
Anti-VEGF Drug market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Anti-VEGF Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For India market, this report focuses on the Anti-VEGF Drug market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in India.



By Company


F. Hoffmann-La Roche Ltd
Amgen Inc
Pfizer, Inc
Xbrane Biopharma AB
Allergan
Bayer AG
Regeneron Pharmaceuticals Inc.
Viatris Inc
Segment by Type
Avastin
Lucentis
Eylea

Segment by Application


Age-related Macular Degeneration
Macular Edema Following Retinal Vein Occlusion
Diabetic Macular Edema
Diabetic Retinopathy
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Anti-VEGF Drug definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Anti-VEGF Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Anti-VEGF Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-VEGF Drug sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Anti-VEGF Drug Product Introduction
1.2 Global Anti-VEGF Drug Outlook 2018 VS 2024 VS 2034
1.2.1 Global Anti-VEGF Drug Sales in US$ Million for the Year 2018-2034
1.2.2 Global Anti-VEGF Drug Sales in Volume for the Year 2018-2034
1.3 India Anti-VEGF Drug Outlook 2018 VS 2024 VS 2034
1.3.1 India Anti-VEGF Drug Sales in US$ Million for the Year 2018-2034
1.3.2 India Anti-VEGF Drug Sales in Volume for the Year 2018-2034
1.4 Anti-VEGF Drug Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of India Anti-VEGF Drug in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Anti-VEGF Drug Market Size, India VS Global, 2018 VS 2024 VS 2034
1.5 Anti-VEGF Drug Market Dynamics
1.5.1 Anti-VEGF Drug Industry Trends
1.5.2 Anti-VEGF Drug Market Drivers
1.5.3 Anti-VEGF Drug Market Challenges
1.5.4 Anti-VEGF Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Anti-VEGF Drug by Type
2.1 Anti-VEGF Drug Market Segment by Type
2.1.1 Avastin
2.1.2 Lucentis
2.1.3 Eylea
2.2 Global Anti-VEGF Drug Market Size by Type
2.2.1 Global Anti-VEGF Drug Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Anti-VEGF Drug Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Anti-VEGF Drug Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 India Anti-VEGF Drug Market Size by Type
2.3.1 India Anti-VEGF Drug Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 India Anti-VEGF Drug Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 India Anti-VEGF Drug Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Anti-VEGF Drug by Application
3.1 Anti-VEGF Drug Market Segment by Application
3.1.1 Age-related Macular Degeneration
3.1.2 Macular Edema Following Retinal Vein Occlusion
3.1.3 Diabetic Macular Edema
3.1.4 Diabetic Retinopathy
3.2 Global Anti-VEGF Drug Market Size by Application
3.2.1 Global Anti-VEGF Drug Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Anti-VEGF Drug Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Anti-VEGF Drug Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 India Anti-VEGF Drug Market Size by Application
3.3.1 India Anti-VEGF Drug Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 India Anti-VEGF Drug Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 India Anti-VEGF Drug Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Anti-VEGF Drug Competitor Landscape by Company
4.1 Global Anti-VEGF Drug Market Size by Company
4.1.1 Global Key Manufacturers of Anti-VEGF Drug, Ranked by Revenue (2024)
4.1.2 Global Anti-VEGF Drug Revenue by Manufacturer (2018-2023)
4.1.3 Global Anti-VEGF Drug Sales by Manufacturer (2018-2023)
4.1.4 Global Anti-VEGF Drug Price by Manufacturer (2018-2023)
4.2 Global Anti-VEGF Drug Concentration Ratio (CR)
4.2.1 Anti-VEGF Drug Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Anti-VEGF Drug in 2024
4.2.3 Global Anti-VEGF Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Anti-VEGF Drug, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Anti-VEGF Drug, Product Offered and Application
4.5 Global Key Manufacturers of Anti-VEGF Drug, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Anti-VEGF Drug Market Size by Company
4.7.1 Key Players of Anti-VEGF Drug in India, Ranked by Revenue (2024)
4.7.2 India Anti-VEGF Drug Revenue by Players (2018-2023)
4.7.3 India Anti-VEGF Drug Sales by Players (2018-2023)
5 Global Anti-VEGF Drug Market Size by Region
5.1 Global Anti-VEGF Drug Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Anti-VEGF Drug Market Size in Volume by Region (2018-2034)
5.2.1 Global Anti-VEGF Drug Sales in Volume by Region: 2018-2023
5.2.2 Global Anti-VEGF Drug Sales in Volume Forecast by Region (2024-2034)
5.3 Global Anti-VEGF Drug Market Size in Value by Region (2018-2034)
5.3.1 Global Anti-VEGF Drug Sales in Value by Region: 2018-2023
5.3.2 Global Anti-VEGF Drug Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Anti-VEGF Drug Market Size YoY Growth 2018-2034
6.2 Americas Anti-VEGF Drug Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Anti-VEGF Drug Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Anti-VEGF Drug Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Anti-VEGF Drug Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Anti-VEGF Drug Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Anti-VEGF Drug Market Size YoY Growth 2018-2034
7.2 EMEA Anti-VEGF Drug Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Anti-VEGF Drug Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Anti-VEGF Drug Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Anti-VEGF Drug Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Anti-VEGF Drug Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Anti-VEGF Drug Market Size YoY Growth 2018-2034
8.2 China Anti-VEGF Drug Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Anti-VEGF Drug Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Anti-VEGF Drug Market Size YoY Growth 2018-2034
9.2 APAC Anti-VEGF Drug Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Anti-VEGF Drug Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Anti-VEGF Drug Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Anti-VEGF Drug Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Anti-VEGF Drug Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 F. Hoffmann-La Roche Ltd
10.1.1 F. Hoffmann-La Roche Ltd Company Information
10.1.2 F. Hoffmann-La Roche Ltd Description and Business Overview
10.1.3 F. Hoffmann-La Roche Ltd Anti-VEGF Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 F. Hoffmann-La Roche Ltd Anti-VEGF Drug Products Offered
10.1.5 F. Hoffmann-La Roche Ltd Recent Development
10.2 Amgen Inc
10.2.1 Amgen Inc Company Information
10.2.2 Amgen Inc Description and Business Overview
10.2.3 Amgen Inc Anti-VEGF Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Amgen Inc Anti-VEGF Drug Products Offered
10.2.5 Amgen Inc Recent Development
10.3 Pfizer, Inc
10.3.1 Pfizer, Inc Company Information
10.3.2 Pfizer, Inc Description and Business Overview
10.3.3 Pfizer, Inc Anti-VEGF Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer, Inc Anti-VEGF Drug Products Offered
10.3.5 Pfizer, Inc Recent Development
10.4 Xbrane Biopharma AB
10.4.1 Xbrane Biopharma AB Company Information
10.4.2 Xbrane Biopharma AB Description and Business Overview
10.4.3 Xbrane Biopharma AB Anti-VEGF Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Xbrane Biopharma AB Anti-VEGF Drug Products Offered
10.4.5 Xbrane Biopharma AB Recent Development
10.5 Allergan
10.5.1 Allergan Company Information
10.5.2 Allergan Description and Business Overview
10.5.3 Allergan Anti-VEGF Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Allergan Anti-VEGF Drug Products Offered
10.5.5 Allergan Recent Development
10.6 Bayer AG
10.6.1 Bayer AG Company Information
10.6.2 Bayer AG Description and Business Overview
10.6.3 Bayer AG Anti-VEGF Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bayer AG Anti-VEGF Drug Products Offered
10.6.5 Bayer AG Recent Development
10.7 Regeneron Pharmaceuticals Inc.
10.7.1 Regeneron Pharmaceuticals Inc. Company Information
10.7.2 Regeneron Pharmaceuticals Inc. Description and Business Overview
10.7.3 Regeneron Pharmaceuticals Inc. Anti-VEGF Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Regeneron Pharmaceuticals Inc. Anti-VEGF Drug Products Offered
10.7.5 Regeneron Pharmaceuticals Inc. Recent Development
10.8 Viatris Inc
10.8.1 Viatris Inc Company Information
10.8.2 Viatris Inc Description and Business Overview
10.8.3 Viatris Inc Anti-VEGF Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Viatris Inc Anti-VEGF Drug Products Offered
10.8.5 Viatris Inc Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Anti-VEGF Drug Industry Chain Analysis
11.2 Anti-VEGF Drug Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Anti-VEGF Drug Production Mode & Process
11.4 Anti-VEGF Drug Sales and Marketing
11.4.1 Anti-VEGF Drug Sales Channels
11.4.2 Anti-VEGF Drug Distributors
11.5 Anti-VEGF Drug Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Anti-VEGF Drug CAGR in Value, India VS Global, 2018 VS 2024 VS 2034
Table 2. Anti-VEGF Drug Market Trends
Table 3. Anti-VEGF Drug Market Drivers
Table 4. Anti-VEGF Drug Market Challenges
Table 5. Anti-VEGF Drug Market Restraints
Table 6. Global Anti-VEGF Drug Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India Anti-VEGF Drug Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Anti-VEGF Drug Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India Anti-VEGF Drug Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Anti-VEGF Drug, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Anti-VEGF Drug Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Anti-VEGF Drug Revenue Share by Manufacturer, 2018-2023
Table 13. Global Anti-VEGF Drug Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Anti-VEGF Drug Sales Share by Manufacturer, 2018-2023
Table 15. Global Anti-VEGF Drug Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Anti-VEGF Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Anti-VEGF Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-VEGF Drug as of 2024)
Table 18. Global Key Manufacturers of Anti-VEGF Drug, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Anti-VEGF Drug, Product Offered and Application
Table 20. Global Key Manufacturers of Anti-VEGF Drug, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Anti-VEGF Drug in India, Ranked by Revenue (2024) & (US$ million)
Table 23. India Anti-VEGF Drug Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Anti-VEGF Drug Revenue Share by Players, (2018-2023)
Table 25. India Anti-VEGF Drug Sales by Players, (K Units), (2018-2023)
Table 26. India Anti-VEGF Drug Sales Share by Players, (2018-2023)
Table 27. Global Anti-VEGF Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Anti-VEGF Drug Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Anti-VEGF Drug Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Anti-VEGF Drug Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Anti-VEGF Drug Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Anti-VEGF Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Anti-VEGF Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Anti-VEGF Drug Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Anti-VEGF Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Anti-VEGF Drug Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Anti-VEGF Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Anti-VEGF Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Anti-VEGF Drug Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Anti-VEGF Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Anti-VEGF Drug Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Anti-VEGF Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Anti-VEGF Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Anti-VEGF Drug Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Anti-VEGF Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Anti-VEGF Drug Sales in Volume by Country (2024-2034) & (K Units)
Table 47. F. Hoffmann-La Roche Ltd Company Information
Table 48. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 49. F. Hoffmann-La Roche Ltd Anti-VEGF Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. F. Hoffmann-La Roche Ltd Anti-VEGF Drug Product
Table 51. F. Hoffmann-La Roche Ltd Recent Development
Table 52. Amgen Inc Company Information
Table 53. Amgen Inc Description and Business Overview
Table 54. Amgen Inc Anti-VEGF Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Amgen Inc Anti-VEGF Drug Product
Table 56. Amgen Inc Recent Development
Table 57. Pfizer, Inc Company Information
Table 58. Pfizer, Inc Description and Business Overview
Table 59. Pfizer, Inc Anti-VEGF Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Pfizer, Inc Anti-VEGF Drug Product
Table 61. Pfizer, Inc Recent Development
Table 62. Xbrane Biopharma AB Company Information
Table 63. Xbrane Biopharma AB Description and Business Overview
Table 64. Xbrane Biopharma AB Anti-VEGF Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Xbrane Biopharma AB Anti-VEGF Drug Product
Table 66. Xbrane Biopharma AB Recent Development
Table 67. Allergan Company Information
Table 68. Allergan Description and Business Overview
Table 69. Allergan Anti-VEGF Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Allergan Anti-VEGF Drug Product
Table 71. Allergan Recent Development
Table 72. Bayer AG Company Information
Table 73. Bayer AG Description and Business Overview
Table 74. Bayer AG Anti-VEGF Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Bayer AG Anti-VEGF Drug Product
Table 76. Bayer AG Recent Development
Table 77. Regeneron Pharmaceuticals Inc. Company Information
Table 78. Regeneron Pharmaceuticals Inc. Description and Business Overview
Table 79. Regeneron Pharmaceuticals Inc. Anti-VEGF Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Regeneron Pharmaceuticals Inc. Anti-VEGF Drug Product
Table 81. Regeneron Pharmaceuticals Inc. Recent Development
Table 82. Viatris Inc Company Information
Table 83. Viatris Inc Description and Business Overview
Table 84. Viatris Inc Anti-VEGF Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Viatris Inc Anti-VEGF Drug Product
Table 86. Viatris Inc Recent Development
Table 87. Key Raw Materials Lists
Table 88. Raw Materials Key Suppliers Lists
Table 89. Anti-VEGF Drug Customers List
Table 90. Anti-VEGF Drug Distributors List
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-VEGF Drug Product Picture
Figure 2. Global Anti-VEGF Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Anti-VEGF Drug Market Size 2018-2034 (US$ Million)
Figure 4. Global Anti-VEGF Drug Sales 2018-2034 (K Units)
Figure 5. India Anti-VEGF Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. India Anti-VEGF Drug Market Size 2018-2034 (US$ Million)
Figure 7. India Anti-VEGF Drug Sales 2018-2034 (K Units)
Figure 8. India Anti-VEGF Drug Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. India Anti-VEGF Drug Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Anti-VEGF Drug Report Years Considered
Figure 11. Product Picture of Avastin
Figure 12. Product Picture of Lucentis
Figure 13. Product Picture of Eylea
Figure 14. Global Anti-VEGF Drug Market Share by Type in 2024 & 2034
Figure 15. Global Anti-VEGF Drug Sales in Value by Type (2018-2034) & (US$ Million)
Figure 16. Global Anti-VEGF Drug Sales Market Share in Value by Type (2018-2034)
Figure 17. Global Anti-VEGF Drug Sales by Type (2018-2034) & (K Units)
Figure 18. Global Anti-VEGF Drug Sales Market Share in Volume by Type (2018-2034)
Figure 19. Global Anti-VEGF Drug Price by Type (2018-2034) & (US$/Unit)
Figure 20. India Anti-VEGF Drug Market Share by Type in 2024 & 2034
Figure 21. India Anti-VEGF Drug Sales in Value by Type (2018-2034) & (US$ Million)
Figure 22. India Anti-VEGF Drug Sales Market Share in Value by Type (2018-2034)
Figure 23. India Anti-VEGF Drug Sales by Type (2018-2034) & (K Units)
Figure 24. India Anti-VEGF Drug Sales Market Share in Volume by Type (2018-2034)
Figure 25. India Anti-VEGF Drug Price by Type (2018-2034) & (US$/Unit)
Figure 26. Product Picture of Age-related Macular Degeneration
Figure 27. Product Picture of Macular Edema Following Retinal Vein Occlusion
Figure 28. Product Picture of Diabetic Macular Edema
Figure 29. Product Picture of Diabetic Retinopathy
Figure 30. Global Anti-VEGF Drug Market Share by Application in 2024 & 2034
Figure 31. Global Anti-VEGF Drug Sales in Value by Application (2018-2034) & (US$ Million)
Figure 32. Global Anti-VEGF Drug Sales Market Share in Value by Application (2018-2034)
Figure 33. Global Anti-VEGF Drug Sales by Application (2018-2034) & (K Units)
Figure 34. Global Anti-VEGF Drug Sales Market Share in Volume by Application (2018-2034)
Figure 35. Global Anti-VEGF Drug Price by Application (2018-2034) & (US$/Unit)
Figure 36. India Anti-VEGF Drug Market Share by Application in 2024 & 2034
Figure 37. India Anti-VEGF Drug Sales in Value by Application (2018-2034) & (US$ Million)
Figure 38. India Anti-VEGF Drug Sales Market Share in Value by Application (2018-2034)
Figure 39. India Anti-VEGF Drug Sales by Application (2018-2034) & (K Units)
Figure 40. India Anti-VEGF Drug Sales Market Share in Volume by Application (2018-2034)
Figure 41. India Anti-VEGF Drug Price by Application (2018-2034) & (US$/Unit)
Figure 42. Americas Anti-VEGF Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 43. Americas Anti-VEGF Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 44. Americas Anti-VEGF Drug Sales by Type (2018-2034) & (K Units)
Figure 45. Americas Anti-VEGF Drug Sales Market Share in Volume by Type (2018-2034)
Figure 46. Americas Anti-VEGF Drug Sales by Application (2018-2034) & (K Units)
Figure 47. Americas Anti-VEGF Drug Sales Market Share in Volume by Application (2018-2034)
Figure 48. United States Anti-VEGF Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. Canada Anti-VEGF Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. Mexico Anti-VEGF Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 51. Brazil Anti-VEGF Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 52. EMEA Anti-VEGF Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 53. EMEA Anti-VEGF Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 54. EMEA Anti-VEGF Drug Sales by Type (2018-2034) & (K Units)
Figure 55. EMEA Anti-VEGF Drug Sales Market Share in Volume by Type (2018-2034)
Figure 56. EMEA Anti-VEGF Drug Sales by Application (2018-2034) & (K Units)
Figure 57. EMEA Anti-VEGF Drug Sales Market Share in Volume by Application (2018-2034)
Figure 58. Europe Anti-VEGF Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 59. Middle East Anti-VEGF Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 60. Africa Anti-VEGF Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 61. China Anti-VEGF Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 62. China Anti-VEGF Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 63. China Anti-VEGF Drug Sales by Type (2018-2034) & (K Units)
Figure 64. China Anti-VEGF Drug Sales Market Share in Volume by Type (2018-2034)
Figure 65. China Anti-VEGF Drug Sales by Application (2018-2034) & (K Units)
Figure 66. China Anti-VEGF Drug Sales Market Share in Volume by Application (2018-2034)
Figure 67. APAC Anti-VEGF Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 68. APAC Anti-VEGF Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 69. APAC Anti-VEGF Drug Sales by Type (2018-2034) & (K Units)
Figure 70. APAC Anti-VEGF Drug Sales Market Share in Volume by Type (2018-2034)
Figure 71. APAC Anti-VEGF Drug Sales by Application (2018-2034) & (K Units)
Figure 72. APAC Anti-VEGF Drug Sales Market Share in Volume by Application (2018-2034)
Figure 73. Japan Anti-VEGF Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. South Korea Anti-VEGF Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. China Taiwan Anti-VEGF Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Anti-VEGF Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 77. India Anti-VEGF Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 78. Anti-VEGF Drug Value Chain
Figure 79. Anti-VEGF Drug Production Process
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries